Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
Journal
Journal for ImmunoTherapy of Cancer
Journal Volume
8
Journal Issue
1
Pages
e000453
Date Issued
2020
Author(s)
Desai J.
Deva S.
Lee J.S.
Yen C.-J.
Chao Y.
Keam B.
Jameson M.
Hou M.-M.
Kang Y.-K.
Markman B.
Lu C.-H.
Rau K.-M.
Lee K.-H.
Horvath L.
Friedlander M.
Hill A.
Sandhu S.
Barlow P.
Wu C.-Y.
Zhang Y.
Liang L.
Wu J.
Paton V.
Millward M.
SDGs
Publisher
BMJ Publishing Group
Type
journal article